DMAC News and Press, DiaMedica Therapeutics Inc. From 08/11/22

DiaMedica Therapeutics Inc. (DMAC) Q2 2022 Earnings Conference Call August 11, 2022, 08:00 AM ET Company Participants Rick Pauls - President and Chief Executive Officer Kirsten Gruis - Chief Medical Officer Scott Kellen - Chief Financial Officer Conference ...

DiaMedica Therapeutics press release ( NASDAQ: DMAC ): Q2 GAAP EPS of -$0.13 beats by $0.05 . For further details see: DiaMedica Therapeutics GAAP EPS of -$0.13 beats by $0.05

Conference Call and Webcast August 11 at 8:00 am Eastern Time / 7:00 am Central Time Company Confident in Plan to Resolve Issues that Led to Clinical Hold of Phase 2/3 ReMEDy2 Trial Proposal to Resume Trial Will be Submitted to FDA in September ...

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today announced that its second quarter 2022 financial results will be released after the markets close on Wednes...

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today announced that the company’s management team will be participating in one-on-one meetings at the upc...

Toronto, Ontario--(Newsfile Corp. - July 21, 2022) - On July 8, 2022, Thomas Von Koch (the " Acquiror "), c/o EQT Partners AB, Box 16509, 103 27 Stockholm, Sweden, acquired indirect ownership, through TomEnterprise AB, of an aggregate of 304,827 common shares (the " Purchased Shares ") of Di...

Toronto, Ontario--(Newsfile Corp. - July 21, 2022) - Thomas Von Koch (the " Acquiror "), c/o EQT Partners AB, Box 16509, 103 27 Stockholm, Sweden, acquired indirect ownership, through TomEnterprise AB, of an aggregate of 304,827 common shares (the " Purchased Shares ") of DiaMedica Therapeut...

Chinese automaker Chijet Motor Company plans to go public through a merger with SPAC Deep Medicine Acquisition Corp. ( NASDAQ: DMAQ ) that pegs the implied enterprise value of the combined company at around $2.55B. The deal, which is slated to close in Q4, is expected to g...

Gainers: Grove Collaborative ( GROV ) +80% . Faraday Future Intelligent Electric ( FFIE ) +30% . Bed Bath & Beyond ( BBBY ) +27% . Dakota Gold ( DC ) +21% . Bolt Biotherapeutics ( BOLT ) +20% . Miromatrix Medical ( MIRO...

Gainers: Longeveron ( LGVN ) +16% . Adverum Biotechnologies ( ADVM ) +13% . 89bio ( ETNB ) +12% . Mainz Biomed ( MYNZ ) +11% . Shineco ( SISI ) +8% . Losers: DiaMedica Therapeutics ( DMAC ) -41% . Cytom...